Effects of all-trans-retinoic acid and all-trans-retinoyl glucuronide in two in vitro systems of distinct biological complexity

Archives of Toxicology

Volumn 75, Issue 8, 2001, Pages 497-504

  Rühl, Ralph ^a   Sass, Jörn ^b   Nau, Heinz ^c   Klug, Stephan ^d  

^a UNIVERSITY OF POTSDAM   (Germany)

^b TYROLEAN CANCER RESEARCH INSTITUTE   (Austria)

^c UNIVERSITY OF VETERINARY MEDICINE HANNOVER   (Germany)

^d FREIE UNIVERSITÄT BERLIN   (Germany)

Author keywords

Embryotoxicity in vitro; Limb bud culture; Retinoic acid; Retinoid; Retinoyl glucuronide; Teratogenicity; Whole embryo culture

Indexed keywords

RETINOIC ACID; RETINOIC ACID DERIVATIVE; RETINOIC ACID GLUCURONIDE; RETINOID; UNCLASSIFIED DRUG;

ANIMAL TISSUE; ARTICLE; CONTROLLED STUDY; CULTURE MEDIUM; EMBRYO; EMBRYO CULTURE; EMBRYO DEVELOPMENT; EMBRYOTOXICITY; HYDROLYSIS; INCUBATION TIME; LIMB BUD; LIPID SOLUBILITY; MOUSE; NONHUMAN; ORGAN CULTURE; PLACENTAL TRANSFER; PRIORITY JOURNAL; RAT; TERATOGENESIS; TOXICITY; TOXICITY TESTING;

ANIMALS; CELLS, CULTURED; EMBRYO; FEMALE; LIMB BUD; MALE; MICE; MICE, INBRED STRAINS; PREGNANCY; RATS; RATS, WISTAR; TERATOGENS; TRETINOIN;

ANIMALIA; ATRA;

EID: 0034758479     PISSN: 03405761     EISSN: None     Source Type: Journal    
DOI: 10.1007/s002040100257     Document Type: Article

References (46)

1. Percutaneous absorption, excretion and metabolism of all-trans-retinoyl β-glucuronide and of all-trans-retinoic acid in the rat
2. Quantitation of rat embryonic development in vitro: A morphological scoring system
3. Inhibition of tumor cell attachment to concacavalin A-coated surfaces as an assay for teratogenic agents: Approaches to validation
4. Qualitative correspondence between in vivo and in vitro activity of teratogenic agents
5. Repeated topical administration of all-trans-retinoic acid and plasma levels of retinoic acids in human
6. 4-Methylpyrazole partially ameliorated the teratogenicity of retinol and reduced the metabolic formation of all-trans-retinoic acid in the mouse
7. Retinoids and their receptors in differentiation, embryogenesis, and neoplasia
8. Retinoyl β-glucuronic acid: A major metabolite of vitamin A in rat bile
9. RAR-Mediated teratogenicity in mice is potentiated by an RXR agonist and reduced by an RAR antagonist: Dissection of retinoid receptor-induced pathways
10. An in vitro assay for teratogens with cultures of rat embryo midbrain and limb bud cells
11. Comparative studies on effects of all-trans-retinoic acid and all-trans-retinoyl-β-D-glucuronide on the development of fetal mouse thymus in an organ culture system
12. Teratological research using in vitro systems. II. Rodent limb bud culture system
13. Effects of retinoid β-glucuronides and N-retinoyl amines on the differentiation of HL-60 cells in vitro
14. Comparative teratogenicity and metabolism of all-trans retinoic acid, all-trans retinoyl β-glucose and all-trans retinoyl β-glucuronide in pregnant sprague-dawley rats
15. Retinoyl β-glucuronide: A nontoxic retinoid for the topical treatment of acne
16. Induction of HL-60 cell differentiation by water-soluble and nitrogen-containing conjugates of retinoic acid and retinol
17. Considerations for in vitro retinoid experiments: Importance of protein interaction
18. Whole embryo culture: Interpretation of abnormal development in vitro
19. Modification and standardisation of the culture of early postimplantation embryos for toxicological studies
20. Influence of 13-cis and all-trans retinoic acid on rat embryonic development in vitro: Correlation with isomerisation and drug transfer to the embryo
21. All-trans retinoic acid and 13-cis-retinoic acid in the rat whole-embryo culture: Abnormal development due to the all-trans isomer
22. Embryonic organs in culture
23. All-trans-retinoic acid and all-trans-retinoyl-glucuronide alter the development of axolotl embryos (Ambystoma mexicanum) in vitro
24. Retinoic acid embryopathy
25. In vitro systems for toxicological studies on the development of mammalian limb buds in a chemically defined medium
26. 13-cis-retinoic acid metabolism in vivo
27. Effects of retinoid glucuronides on mammary gland development in organ culture
28. Retinoid glucuronides do not interact with retinoid binding proteins
29. A short-term screening test for teratogens using differentiating neuroblastoma cells in vitro
30. Teratogenicity of vitamin A and retinoids
31. All-trans-retinoyl-β-glucuronide is a potent teratogen in the mouse because of extensive metabolism to all-trans-retinoic acid
32. Current developments of oral retinoid therapy with three generations of drugs
33. Microtiter micromass cultures of limb-bud mesenchymal cells
34. Prescreening for environmental teratogens using cultured mesenchymal cells from the human embryonic palate
35. Clinical pharmacokinetics of tretinoin
36. Influence of all-trans-retinoyl-β-D-glucuronide on growth and differentiation in two in vitro systems of different biological complexity
37. Retinoyl-β-glucuronide: Lack of binding to receptor proteins of retinoic acid as related to biological activity
38. Effects of all-trans-retinoyl-β-D-glucuronide and all-trans-retinoic acid on chondrogenesis and retinoid metabolism in mouse limb bud mesenchymal cells in vitro
39. Morphogenesis of malformations in hamster caused by retinoic acid: Relation to dose and stage at treatment
40. Development of the fetal mouse palate in suspension organ culture
41. Retinoid receptor-selective agonists and their action in the skin
42. Specific antagonists of retinoid toxicity in mice
43. Proximate retinoid teratogens
44. Role of retinoids in normal and diseased skin
45. Metabolism in vivo of all-trans-retinoic acid. Biosynthesis of 13-cis-retinoic acid and all-trans- and 13-cis-retinoyl glucuronides in the intestinal mucosa of the rat
46. Induction of differentiation of human promyelocytic leukaemia cell line HL-60 by retinoyl glucuronide, a biologically active metabolite of vitamin A